Usefulness of strongyloides stercoralis serology in the management of patients with eosinophilia

American Journal of Tropical Medicine and Hygiene

Volumn 90, Issue 5, 2014, Pages 830-834

  Salvador, Fernando ^a,b   Sulleiro, Elena ^a,b   Sánchez Montalv́a, Adrián ^a,b   Saugar, José María ^c   Rodriǵuez, Esperanza ^c   Pahissa, Albert ^a,b   Molina, Israel ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b PROSICS Barcelona ^*  (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IVERMECTIN;

ADULT; AGED; ARTICLE; ASCARIASIS; CELL COUNT; DIENTAMOEBIASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPTICAL DENSITY; SEROLOGY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; WILCOXON SIGNED RANKS TEST;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, HELMINTH; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FECES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; IVERMECTIN; LARVA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; YOUNG ADULT;

EID: 84900463232     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0678     Document Type: Article

References (27)

1. Barnett ED, Weld LH, McCarthy AE, So H, Walker PF, Stauffer W, Cetron M; GeoSentinel Surveillance Network, 2013. Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997-2009, part 1: US-bound migrants evaluated by comprehensive protocol-based health assessment. Clin Infect Dis 56: 913-924.
2. World Health Organization, Strongyloidiasis. Available at: www.who.int/neglected-diseases/diseases/strongyloidiasis/en/. Accessed November 1, 2013.
3. Repetto SA, Durán PA, Lasala MB, González-Cappa SM, 2010. High rate of Strongyloidosis infection, out of endemic area, in patients with eosinophilia and without risk of exogenous reinfections. Am J Trop Med Hyg 82: 1088-1093.
4. Keiser PB, Nutman TB, 2004. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17: 208-217. (Pubitemid 38120934)
5. Siddiqui AA, Berck SL, 2001. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33: 1040-1047. (Pubitemid 32907108)
6. Kobayashi J, Sato Y, Toma H, Takara M, Shiroma Y, 1994. Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis. Diagn Microbiol Infect Dis 18: 19-23.
7. Biggs BA, Caruana S, Mihrshahi S, Jolley D, Leydon J, Chea L, Nuon S, 2009. Short report: management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful? Am J Trop Med Hyg 80: 788-791.
8. Bon B, Houze S, Talabani H, Magne D, Belkadi G, Develoux M, Senghor Y, Chandenier J, Ancelle T, Hennequin C, 2010. Evaluation of a rapid enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis. J Clin Microbiol 48: 1716-1719.
9. Suputtamongkol Y, Premasathian N, Bhumimuang K, Waywa D, Nilganuwong S, Karuphong E, Anekthananon T, Wanachiwanawin D, Silpasakorn S, 2011. Efficacy and safety of single and double doses of Ivermectin versus 7-day high dose Albendazole for chronic strongyloidiasis. PLoS Negl Trop Dis 5: e1044.
10. Díaz-Menéndez M, Pérez-Molina JA, Serre N, Treviño B, Torrús D, Matarranz M, Martín E, Rojo-Marcos G, Aguilera P, Rico A, Suárez-García I, López-Velez R; Grupo de trabajo +Redivi,2012. Imported diseases by immigrants and travelers: results from the Cooperative Network for the study of Imported Diseases by Immigrants and Travelers + Redivi. Enferm Infecc Microbiol Clin 30: 528-534.
11. Valerio L, Roure S, Fernández-Rivas G, Basile L, Martínez-Cuevas O, Ballesteros AL, Ramos X, Sabrià M; North Metropolitan Working Group on Imported Diseases, 2013. Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012. Trans R Soc Trop Med Hyg 107: 465-470.
12. Dreyer G, Fernandes-Silva E, Alves S, Rocha A, Albuquerque R, Addiss D, 1996. Patterns of detection of Strongyloides stercoralis in stool specimens: implications for diagnosis and clinical trials. J Clin Microbiol 34: 2569-2571. (Pubitemid 26307813)
13. Uparanukraw P, Phongsri S, Morakote N, 1999. Fluctuations of larval excretion in Strongyloides stercoralis infection. Am J Trop Med Hyg 60: 967-973. (Pubitemid 29296223)
14. Nielsen PB, Mojon M, 1987. Improved diagnosis of Strongyloides stercoralis by seven consecutive stool specimens. Zentralbl Bakteriol Mikrobiol Hyg [A] 263: 616-618. (Pubitemid 17067670)
15. Requena-Méndez A, Chiodini P, Bisoffi Z, Buonfrate D, Gotuzzo E, Muñoz J, 2013. The laboratory diagnosis and follow-up of strongyloidiasis: a systematic review. PLoS Negl Trop Dis 7: e2002.
16. Abdul-Fattah MM, Nasr ME, Yousef SM, Ibraheem MI, Abdul-Wahhab SE, Soliman HM, 1995. Efficacy of ELISA in diagnosis of strongyloidiasis among the immune-compromised patients. J Egypt Soc Parasitol 25: 491-498.
17. Salvador F, Molina I, Sulleiro E, Burgos J, Curran A, Van den Eynde E, Villar del Saz S, Navarro J, Crespo M, Ocaña I, Ribera E, Falcó V, Pahissa A, 2013. Tropical diseases screening in immigrant patients with HIV infection in a European country. Am J Trop Med Hyg 88: 1196-1202.
18. Llenas-García J, Fiorante S, Salto E, Maseda D, Rodríguez V, Matarranz M, Hernando A, Rubio R, Pulido F, 2013. Should we look for Strongyloides stercoralis in foreign-born HIV-infected persons? J Immigr Minor Health 15: 796-802.
19. Karunajeewa H, Kelly H, Leslie D, Leydon J, Saykao P, Biggs BA, 2006. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis. J Travel Med 13: 84-91.
20. Page WA, Dempsey K, McCarthy JS, 2006. Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy. Trans R Soc Trop Med Hyg 100: 1056-1062. (Pubitemid 44309207)
21. Lindo JF, Atkins NS, Lee MG, Robinson RD, Bundy DAP, 1996. Parasite-specific serum IgG following successful treatment of endemic strongyloidiasis using ivermectin. Trans R Soc Trop Med Hyg 90: 702-703. (Pubitemid 27011177)
22. Loutfy MR, Wilson M, Keystone JS, Kain KC, 2002. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 66: 749-752. (Pubitemid 35001049)
23. Bisoffi Z, Buonfrate D, Angheben A, Boscolo M, Anselmi M, Marocco S, Monteiro G, Gobbo M, Bisoffi G, Gobbi F, 2011. Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis. PLoS Negl Trop Dis 5: e1254.
24. Krolewiecki AJ, Ramanathan R, Fink V, McAuliffe I, Cajal SP, Won K, Juarez M, Di Paolo A, Tapia L, Acosta N, Lee R, Lammie P, Abraham D, Nutman TB, 2010. Improved diagnosis of Strongyloides stercoralis using recombinant antigenbased serologies in a community-wide study in Northern Argentina. Vaccine Immunol 17: 1624-1630.
25. El-Badry AA, 2009. ELISA-based coproantigen in human strongyloidiasis: a diagnostic method correlating with worm burden. J Egypt Soc Parasitol 39: 757-768.
26. Kramme S, Nissen N, Soblik H, Erttmann K, Tannich E, Fleisher B, Panning M, Brattig N, 2011. Novel real-time PCR for the universal detection of Strongyloides species. J Med Microbiol 60: 454-458.
27. Verweij JJ, Canales M, Polman K, Ziem J, Brienen EA, Polderman AM, van Lieshout L, 2009. Molecular diagnosis of Strongyloides stercoralis in fecal samples using real-time PCR. Trans R Soc Trop Med Hyg 103: 342-346.